Showing results (21-30 of 224) with videos related to
Sort By:
Pageof 23
Nephrology (Carlton, Vic.)|September 27, 2024
Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissueJonathan BarrattClinical Journal of the American Society of Nephrology : CJASN|April 3, 2015
Statins and Cardiovascular Primary Prevention in CKD: A Meta-AnalysisRupert W Major, Chee Kay Cheung, Laura J Gray, et al.Kidney International Reports|December 22, 2025
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY TrialVlado Perkovic, Jonathan Barratt, Richard Lafayette, et al.Frontiers in Immunology|September 27, 2021
Complement Factor D as a Strategic Target for Regulating the Alternative Complement PathwayJonathan Barratt, Ilene WeitzKidney Diseases (Basel, Switzerland)|August 19, 2016
The Genetics of IgA Nephropathy: An Overview from Western CountriesJohn Feehally, Jonathan BarrattKidney International|April 20, 2021
SGLT-2 inhibition in IgA nephropathy: the new standard of care?Jonathan Barratt, Jürgen FloegeSeminars in Nephrology|August 16, 2011
Primary IgA nephropathy: new insights into pathogenesisJonathan Barratt, John FeehallySeminars in Immunopathology|August 21, 2021
Is IgA nephropathy the same disease in different parts of the world?Hong Zhang, Jonathan BarrattCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 19, 2007
Urine proteomics: the present and future of measuring urinary protein components in diseaseJonathan Barratt, Peter TophamNature Reviews. Nephrology|October 27, 2009
Glomerular disease: sugars and immune complex formation in IgA nephropathyJonathan Barratt, Frank EitnerPageof 23